ADC Therapeutics SA (ADCT) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Adc Therapeutics Sa.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:01.330 -- 00:00:07.277 Good morning, ladies and gentlemen, and welcome to the ADC Therapeutics FA-ADCT 00:00:07.277 -- 00:00:12.383 Q2 2025 Earnings Conference Call. At this time, all lines are in the listen-only 00:00:12.383 -- 00:00:16.949 mode. Following the presentation, we will conduct a question and answer session. 00:00:16.949 -- 00:00:20.653 If at any time during this call you require immediate assistance, please press star zero 00:00:20.653 -- 00:00:26.220 for the operator. This call is being recorded on Tuesday, August 12, 2025. 00:00:26.220 -- 00:00:30.237 I will now turn the call over to Nicole Riley, Head of Investor Relations and Corporate 00:00:30.237 -- 00:00:32.940 Communications for ADC Therapeutics. 00:00:32.940 -- 00:00:35.762 Nicole, please go ahead. 00:00:37.606 -- 00:00:39.128 Thank you, operator. 00:00:39.128 -- 00:00:44.756 Today, we issued a press release announcing our second quarter 2025 financial 00:00:44.756 -- 00:00:50.823 results and business updates. This release and the slides we will use in today's presentation 00:00:50.823 -- 00:00:56.190 are available on the investor section of the ADC Therapeutics website. 00:00:56.190 -- 00:01:01.277 I'm joined on today's call by our Chief Executive Officer, Amit Malik, who will 00:01:01.277 -- 00:01:05.483 discuss our operational performance and recent business highlights. 00:01:05.483 -- 00:01:10.270 Our Chief Medical Officer, Mohammad Zaki, who will discuss our clinical programs and 00:01:10.270 -- 00:01:15.298 updates, followed by our Chief Financial Officer, Pepe Carmona, who will 00:01:15.298 -- 00:01:19.584 review our second quarter 2025 financial results. 00:01:19.584 -- 00:01:23.086 We will then open the call to questions. 00:01:23.461 -- 00:01:27.506 Before we begin, I wou...